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THE SUCCESSFUL PREDICTION of objec-
tive remission in breast tumours following
hormonal therapy may be improved
if the functioning of the oestrogen-
receptor (RE) system is assessed by the
presence of both cytosol and nuclear
RE (RE, and REN) (Garola & McGuire,
1977; Leake et al., 1981), or both REc
and progesterone receptor (RP) (Horwitz
et al., 1975; McGuire et al., 1977; King
et al., 1979). However, there are certain
practicalities that often preclude satis-
factory receptor analyses, including in-
sufficient tissue for saturation analysis
and the instability of RP and REN under
in vitro assay conditions. The regulation
of REN binding in animal tissues may be
controlled by a factor which activates
REC, increasing its affinity for nuclear
binding sites and transforming it to the
REN (Thrower et al., 1976; White et al.,
1978; Myatt et al., 1982). The concentra-
tion of this putative activating factor is
assessed by the bindingofREC to artificial
nuclear acceptor matrices including oligo-
(dT)-cellulose and DNA-cellulose. Varia-
tions in the capability of breast-tumour
REC tobindtoDNA-cellulose, as described
by Sato et al. (1981), may influence the
extent of REN binding. Breast tumours
that contain REc which cannot be con-
verted to REN exhibit a poor objective
response to endocrine therapy (Kute
et at., 1978). In the present study the
concentration of RE, and its ability to
bind to oligo(dT)-cellulose has been
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measured and correlated with the presence
of REN and RPC. This may evaluate
whether the presence of an activated
RE (i.e. capable of binding to an artificial
nuclear matrix) is a determinant of a
functionally responsive receptor system
in human breast tumours.
Sixty-three biopsy specimens from 61
patients (22-79 years of age) with histo-
logically confirmed primary breast car-
cinoma were studied. Thirty-eight patients
(62.3%) were postmenopausal and the
remaining 23 (37.7%) premenopausal.
Tumour tissue was stored in liquid N2
for not more than 2 months. Tissues were
pulverized in a microdismembrator (Braun
Instruments Ltd, West Germany) and
resuspended in buffer (10 mm phosphate;
1.5 mM diK EDTA; 10 mm monothio-
glycerol (pH 7.4) containing 30% glycerol)
to a concentration of 1:8 (w/v). Subsequent
procedures were performed at 4°C. The
suspension was stirred for 10 min, fol-
lowed by centrifugation at 2000 g for
15 min to yield a nuclear pellet and super-
natant (cytosol) fraction. REC and R.P
were assayed using the method of King
et al. (1979) in 200 pl aliquots of the super-
natantat 4°Covernight. REcwasmeasured
using 5 nM (3H)-oestradiol with 1 ,uM
diethylstilboestrol as competitor, and RP
using 10 nM(3H)-progesterone plus 1 pM
cortisol with 1 IM norethisterone as com-
petitor. Labelled REC complexes were
chromatographed on columns containing
100 mg oligo(dT)-cellulose (Myatt et al.,OLIGO(dT)-CELLULOSE BINDING IN BREAST TUMOURS
TABLE I.-Breast-tumour sex-steroid receptor concentrations
Premenopausal
Mean +s.e.
(fmol/mg wet wt) P * O/o +ve Pt
0-60+0-22 <0-01 69-6 -
0-13+0-04 <0 05 29-4 0-023
0-36+0-16 55-0
0-27+0-05 <0-1 75 0
0-25+0 06 56-5 0-046
n
23
17
21
21
23
Postmenopausal
C- --
Mean + s.e.
(fmol/mg wet wt) 0o +ve n
2-82+0-60 77-5 40
0-47+0-12 64-7 34
0-49+0-10 65-8 38
0-56+0-10 71-1 38
0-19+0-08 31-6 38
* FoI- difference in concenitration from postmenopausal using t test
t For difference in incidence from postmenopausal using Fisher's exact test
t Binding to oligo(dT)-cellulose
1978). The crude nuclear pellets were
resuspended and washed x 3 in TEDG
buffer (10 mm Tris/HCl; 1-5 mm EDTA;
1 mM dithiothreitol containing 10% gly-
cerol, pH 7.6) before resuspension in 9
volumes (w/v) of buffer. Aliquots (200 pAl)
of this suspension were incubated with
10 nM (3H)-oestradiol with 2 ,tM diethyl-
stilboestrol as competitor, for 1 h at 30°C
(total receptor) and 4°C (available recep-
tor). Nuclei were then washed x 3 with
1 ml of 1% BSA in TEDG buffer, followed
by a final wash with 1 ml TEDG, after
which radioactivity was extracted with
2 x 2 ml ethanol and counted. A receptor
concentration of > 0 1 fmol/mg wet tissue
was taken as positive, for all parameters.
In the postmenopausal group the con-
centration of REC was significantly in-
creased, in agreement with other findings
(Hawkins et al., 1980), as was its capacity
to bind to oligo(dT)-cellulose (Table I).
The control of receptor content and its
ability to bind to oligo(dT)-cellulose (by
interacting with activating factor to
produce the 5S form of the receptor
(Myatt et al., 1982)) are apparently
regulated quantitatively in a similar
manner. There was no significantdifference
in concentration of RPC between the 2
groups, in agreement with others (Barnes
et al., 1979; Lippman, 1980). The content
of REN (30°C) was not significantly
different in the 2 groups, but in the
postmenopausal group the concentration
of available REN (4°C) was significantly
increased. The ratios of both REN30 and
REN4 to RPC were higher in the post-
menopausal group (REN30/RPc :1U31 +
0.26 (n= 7) pre- vs. 4-44 + 1-16 (n= 13)
post-, P < 0-02; REN4/RPC: 1-46 + 0'50
(n=11) pre- vs. 4-38+1-14 (n=13) post-,
P < 0.05).
There was no significant difference
in the incidence of REC or REN (30°C
and 4°C) between the 2 groups. The
incidence of RP+ tumours was signifi-
cantly lower in the postmenopausal group,
whilst the incidence of RE binding to
oligo(dT)-cellulose wassignificantlyhigher.
The absence of changes in total nuclear
receptor (REN30) despite the postmeno-
pausal increase in REC and plasma
oestrogen may be due to the predominance
of oestrone, which has a relatively low
affinity for RE, in the plasma of post-
menopausal women (Siiteri & MacDonald,
1973).
The presence of REN4 in human breast
tumours has been previously reported
TABLE II.-Frequency of steroid-receptor
combinations in breast tumours
Premenopausal
Postmenopausal
Premenopausal
Postmenopausal
Premenopausal
Postmenopausal
RPe
(No.
patients)
REc REN30 +
-
+ + 7 0
+ - 3 4
+ + 8 13
+ - 1 6
REN4
+ +
+_
+
7 3
3 1
+ 8 16
- 1 3
dT
+ + 5 0
+ - 1 4
+ + 12 9
+ - 0 6
REc
dT$
REN30
REN4
RPc
965966 L. MYATT ET AL.
(Garola & McGuire, 1977; Kiang, 1977,
Laing et al., 1977). The increase in the
proportion of REN4 that occurs in the
postmenopausal group is in agreement
with Thorsen (1979) and may be explained
by the nature of the ligand that occupies
the REN. As oestrogens may be formed
by breast-tumour tissue in situ (Miller
& Forest, 1974; Adams & Li, 1975; Li
et al., 1976) from precursors in plasma,
a simplistic interpretation of the origin
of REN based upon the nature of the cir-
culating oestrogen may not be entirely
valid. However, the change in content
and proportion of REN4 in pre- and post-
menopausal groups suggests that they
are not simply a constitutive form of
nuclear receptor.
The low incidence of RP+ tumours in
postmenopausal women may be related
to the value of receptor content used in
discriminating between tumours or, alter-
natively, to insufficient oestrogen stimu-
lation in the postmenopausal patient
(McGuire, 1980). A positive correlation
exists between RE content and response
to endocrine therapy (McGuire, 1980;
Lippman, 1980) with postmenopausal
patients showing the most favourable
response (Leake et al., 1981). A better
index of function may be the ratio RP/
REN, as proposed for the assessment of
human endometrium (King & Whitehead,
1980).
The rationale that each parameter
represents a functional component of
the receptor system has been verified by
the improved prediction rate for response
to hormone therapy when receptor para-
meters were measured simultaneously. In
our group of premenopausal patients
(Table II) selecting REc+ and REN30+, or
REC+ and REN4+, was associated with
being RP+ (7/7 and 7/10 respectively). All
tumours that were REc+ and positive for
binding to oligo(dT)-cellulose were also
RP+ (5/5). Binding to oligo(dT)-cellulose is
therefore as good a parameter as REN con-
tent in predicting the presence of RP and
hence response to hormone therapy.
In the postmenopausal REC+ tumours
there was little correlation between bind-
ing to oligo(dT)-cellulose or REN content
and RP positivity. In contrast to the 78%
of REC+ tumours which were positive for
binding to oligo(dT)-cellulose, only 37%
were RP+. In view ofthe apparent associ-
ation between RE content and response
to therapy, the postmenopausal group
would be expected to have the better
prognosis. However, on the basis of the
simultaneous incidence of REC and RP,
the postmenopausal group (37%) appears
less favourable than the premenopausal
group (68%). Binding to oligo(dT)-cellu-
lose in RE+ tumours (50% pre-, 78%
postmenopausal) may be a better deter-
minant of receptor function, and hence
response to hormone therapy.
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